Director/Executive Director of Business Development

Proclinical; Ireland; Remote; EUR 214,000 - 348,000; Full time

Job summary

Proclinical is seeking an experienced oncology business development leader to drive global licensing-out transactions and strategic partnerships for its oncology portfolio.

The role involves end-to-end deal execution, asset valuation, and senior-level partnering across regions, working with the CBO and executive teams to maximize asset value. Fluency in English is required; PhD preferred, MBA a plus.

Qualifications

• Advanced degree in life sciences, medicine, pharmacy, oncology, biotechnology, or related field; PhD preferred.
• Experience in biopharmaceutical business development, licensing, corporate development, or strategic partnering at director/executive level.
• Strong oncology drug development knowledge, clinical trial design, and commercial considerations.
• Proven ability in cross-border negotiations and multi-disciplinary transaction teams.
• Established relationships with pharma/biotech oncology players.

Responsibilities

• Lead end-to-end global oncology licensing-out transactions from identification to deal closing.
• Drive ongoing licensing discussions and advance transactions from term sheet to definitive agreements.
• Develop asset-specific licensing strategies based on data, MOA, and market opportunities.
• Negotiate upfronts, milestones, royalties, IP, and development/commercial responsibilities.
• Advise executive management on monetization strategies and transaction priorities.

Skills

Oncology BD

Negotiation

Cross-functional leadership

Strategic thinking

English fluency

Education

PhD preferred

MBA an advantage

Job description

Director/Executive Director of Business Development - Permanent - Remote US

Do you have the vision, influence, and deal-making expertise to shape the future of cancer therapeutics?

Proclinical is seeking an experienced oncology business development leader to drive global licensing-out transactions and strategic partnerships for the company's oncology pipeline.

Primary Responsibilities:

The successful candidate will lead licensing and partnering initiatives, advancing ongoing transactions from the Term Sheet stage toward definitive licensing agreements and successful deal execution. This role requires a strong combination of oncology drug development knowledge, transaction execution expertise, commercial acumen, and senior-level partnering capabilities. The candidate will work closely with the CBO, executive management, and cross-functional teams to maximize the global commercial value of the company's oncology assets.

Skills & Requirements:

• Advanced degree in life sciences, medicine, pharmacy, oncology, biotechnology, or a related field. A PhD is preferred; an MBA is an advantage.
• Proven years of relevant experience in biopharmaceutical business development, licensing, corporate development, or strategic partnering, with seniority appropriate to Director - Executive Director level.
• Strong understanding of oncology drug development, clinical trial design, competitive landscapes, and the commercial considerations relevant to oncology assets.
  Demonstrated experience leading or materially contributing to oncology licensing-out transactions, including term sheet negotiation, due diligence, and definitive agreement execution.
• Established relationships with pharmaceutical and biotechnology companies active in oncology development and commercialization.
• Strong knowledge of licensing economics, transaction structuring, intellectual property, clinical and regulatory milestones, and global commercialization rights.
• Proven ability to lead complex cross-border negotiations and coordinate multidisciplinary transaction teams.
• Excellent strategic thinking, negotiation, communication, and stakeholder management skills.
• Fluency in English is required; Mandarin Chinese proficiency is preferred.

The Director's responsibilities will be:

Oncology Licensing-out & Deal Execution

• Lead end-to-end global licensing-out transactions for oncology assets, from partner identification and initial engagement through due diligence, term sheet negotiation, definitive agreements, and deal closing.
• Drive ongoing licensing discussions and advance transactions from the Term Sheet stage toward definitive licensing agreements.
• Develop asset-specific licensing strategies based on clinical data, mechanism of action, competitive positioning, target patient populations, and market opportunities.
• Lead negotiations on upfront payments, development and regulatory milestones, royalties, territorial rights, exclusivity, intellectual property, and development and commercialization responsibilities.
• Develop transaction structures that optimize asset value while addressing commercial, clinical, regulatory, and execution risks.

Global Oncology Business Development & Partnering

• Develop and execute global licensing-out strategies for oncology pipeline assets.
• Identify and engage potential partners, including multinational pharmaceutical companies, oncology-focused biotechnology companies, and regional pharmaceutical partners.
• Build senior-level relationships with global oncology business development, licensing, and therapeutic area leadership teams.
• Evaluate partnering opportunities across relevant oncology indications, treatment modalities, and development stages.
• Represent the company in strategic partnering meetings, international oncology conferences, and senior-level licensing negotiations.

Oncology Market Intelligence & Asset Valuation

• Analyze oncology treatment landscapes, standards of care, competitive pipelines, clinical data, unmet medical needs, and commercial opportunities.
• Assess the differentiation and partnering potential of pipeline assets based on efficacy, safety, biomarker strategies, target populations, and competitive positioning.
• Develop commercial assessments and transaction valuation models in collaboration with clinical, scientific, and finance teams.
• Monitor comparable oncology licensing transactions and market trends to inform negotiation strategies and deal structures.
• Provide recommendations on asset prioritization, licensing timing, target markets, and partner selection.

Executive-level Strategic Contribution

• Advise the CBO and executive management on oncology pipeline monetization, licensing strategy, partnership opportunities, and transaction priorities.
• Lead high-level commercial negotiations with prospective partners and communicate transaction progress and risks to senior management.
• Contribute to the company's global growth strategy through strategic partnerships and value-maximizing licensing transactions.

Compensation:

• $240,000 to $390,000 per annum.